Loading clinical trials...
Loading clinical trials...
A Phase I , Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of EGT0001474 In Healthy Volunteers
Conditions
Interventions
EGT0001474
Placebo
Locations
1
United States
Covance Clinical Research Unit
Madison, Wisconsin, United States
Start Date
February 1, 2009
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
June 6, 2019
Lead Sponsor
Theracos
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions